Cellular Toxicity and Apoptosis Studies in Osteocarcinoma Cells, a Comparison of 177Lu-EDTMP and Lu-EDTMP

Publisher： Bentham Science Publishers

E-ISSN： 1874-4729|6|3|146-151

ISSN： 1874-4710

Source： Current Radiopharmaceuticals, Vol.6, Iss.3, 2013-09, pp. : 146-151

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetic, Dosimetry and Toxicity Study of 177Lu-EDTMP in Patients: Phase 0/I study

By  

Current Radiopharmaceuticals, Vol. 9, Iss. 1, 2015-11 ,pp. : 71-84

Bentham Science Publishers

Access to resources Recommend Favorite

Evaluation of 177Lu-EDTMP in Dogs with Spontaneous Tumor Involving Bone: Pharmacokinetics, Dosimetry and Therapeutic Efficacy

By  

Current Radiopharmaceuticals, Vol. 9, Iss. 1, 2015-11 ,pp. : 64-70

Bentham Science Publishers

Access to resources Recommend Favorite

Radiation Dosimetry Aspects of 177Lu

By  

Current Radiopharmaceuticals, Vol. 8, Iss. 2, 2015-08 ,pp. : 139-144

Bentham Science Publishers

Access to resources Recommend Favorite

Studies on Efficacy of a Novel 177Lu-Labeled Porphyrin Derivative in Regression of Tumors in Mouse Model

By  

Current Radiopharmaceuticals, Vol. 4, Iss. 2, 2011-04 ,pp. : 150-160

Bentham Science Publishers

Access to resources Recommend Favorite

Consequences of meta-stable 177mLu admixture in 177Lu for patient dosimetry

By  

Current Radiopharmaceuticals, Vol. 8, Iss. 2, 2015-08 ,pp. : 145-149

Bentham Science Publishers

Access to resources Recommend Favorite